The replication of herpes simplex virus (HSV) type 1 in macrophages grown from spleen cells of mouse strains susceptible to HSV infection in vivo was very sensitive to interferon (IFN). Different types of mouse IFN (c~, fl, ~,) exhibited similar antiviral activities. However, treatment of cells with IFN-~ in combination with IEN-~ or IFN-/3 resulted in a synergistic inhibition of virus growth. As shown by assaying HSV DNA polymerase, IFN inhibited expression of the/3-genes. Inhibition of enzyme induction correlated well with the reduction of viral yield. Induction of HSV DNA polymerase was delayed by IFN in a dose-dependent manner. These results show that IFN inhibits HSV replication at an early step prior to or during the synthesis of/3-proteins.
Paucker's laboratory was a gift of Dr R. M. Friedman to Dr H. Jacobsen. Mouse IFN-y (3.6 x 106 IU/mg) purified according to Gribaudo et al. (1984) was kindly donated by Dr S. Landolfo (Institute of Microbiology, University of Turin, Italy). Macrophage IFN (IFN-Mq~; 1 x 10 s IU/mg) was induced in bone marrow macrophages by 10-carboxymethyl-9-acridanone as described by Storch & Kirchner (1982) . It was partially purified using the procedure of G. Brehm et al. (unpublished) . Recombinant human IFN-c~ 2 (1 x 107 IU/mg) was given by Dr S. Hiemstra (Essex Pharma, Mtinchen, F.R.G.). Antiserum against mouse IFN-~/fl (5 x 104 IU/ml) was purchased from Stratech Scientific Ltd. Interferon titrations were performed as described by Zawatzky et al. (1982) using L-cells and vesicular stomatitis virus (VSV). Cells were used for experiments at about 90~o confluency. At this time, cell number per dish was about 1 x 106. Cells were washed and incubated with IFN for 18 h. Prior to infection macrophages were washed three times to remove IFN and infected with 0.2 ml virus at a multiplicity of infection (m.o.i.) as indicated in each experiment. After virus adsorption for t h, cells were washed again, supplemented with 2.0 ml of fresh medium and incubated for various times. Infected cells were stored at -70°C until assay of virus yield. All experiments were carried out with duplicate cell cultures.
For assaying DNA polymerase activity, cell monolayers were washed twice with cold phosphate-buffered saline and once with cold extraction buffer (10 mM-Tris HCI pH 8.0, 2 mM-2-mercaptoethanol, 20~o glycerol). Cells were incubated for 5 min at 4 °C in 0.4 ml extraction buffer, scraped off with a rubber policeman and stored at -70 °C. After thawing, postmitochondrial supernatants were prepared by centrifugation at 12 000 g for 15 min at 4 °C. The supernatants were kept at -70 °C. Protein concentrations were determined according to the Bio-Rad protein assay (Bradford, 1976) .
Enzyme activities were determined as described by Panet & Falk (1983) and Purifoy & Benyesh-Melnick (1975) . The incorporation of [3H]TTP (sp. act. 50 Ci/mmol) into TCAinsoluble material was measured with activated DNA as template primer. The assay mixture contained KC1 (0-2 M) to suppress cellular DNA polymerases. Residual cellular enzyme activities are included in the figures. All enzyme assays were performed in triplicate.
Macrophages grown from spleens of DBA/2 mice were permissive for HSV and HSV replication exhibited a high sensitivity to IFN. Different types of mouse IFN (~, fl, 7) reduced virus titres by more than 2 log10, whereas HSV replication was not affected by Hu-IFN-~2 (Table 1) . After stimulation with HSV, macrophage cultures produced IFN-~/fl (Kirchner et al., 1983) . Compared to other IFNs, endogenous macrophage IFN (IFN-M4~) induced by 10-carboxymethyl-9-acridanone in bone marrow-derived macrophage cultures and partially purified (G. Brehm et al., unpublished results) did not differ in its activity against HSV. Inhibition was shown to be synergistic with combinations of IFN-y and IFN-~, IFN-7 and IFNfl, or IFN-~, and IFN-M4~. For example, log10 reduction of virus titre was 3.3 for a mixture of 100 The kinetics of viral replication was analysed in IFN-treated macrophages. As expected, infection at a multiplicity of 4 resulted in high virus titres and cell death after the first round of replication (Fig. 2a) . Compared to control cells only few infectious virions were produced in IFN-treated cells. Inhibition was similar with 20 and 500 IU IFN per ml 9 h after infection. However, some hours later reduction of virus yield was more pronounced with higher IFN doses. There was a marked effect of IFN on the induction of HSV fl-protein synthesis (Fig. 2b) . In untreated macrophages the maximum of viral DNA polymerase activity was reached 7 to 9 h after infection and an increase of enzyme activity was first observed 3 h after infection, IFN decreased the maximum of enzyme activity and delayed enzyme induction in a dose-dependent manner. With 20 IU IFN-ct/fl per ml, the first increase of DNA polymerase was measured 5 h after infection. After pretreatment of cells with 500 IU IFN-u/fl per ml, viral enzyme was first detectable 7 h after infection.
So far, little is known about the molecular events leading to the inhibition of herpesviruses in IFN-treated cells. We have studied IFN-mediated inhibition of HSV replication in splenic mouse macrophages. One reason for selecting these cells was the sensitivity of the macrophage-HSV system to IFN. Compared to other systems (Panet & Falk, 1983; Rasmussen et al., 1984) inhibition of HSV in mouse macrophages by IFN was much more effective. Previously, most experiments concerning IFN-mediated inhibition of HSV replication were done in permanent cell lines (Lerner & Bailey, 1976; Fish et al., 1983) . Treatment of macrophages with a mixture of IFN-y and other IFN types resulted in a more than additive inhibition of virus growth. Similar findings have been made for inhibition of Mengovirus in L-cells (Fleischmann et al., 1979) or cell growth inhibition and inhibition of HSV in human melanoma cells (Czarniecki et al., t984) . The phenomenon of potentiation may indicate that IFN-y and IFN-a//3 activate cells by different mechanisms. It has been shown that an additional set of polypeptides is induced by treatment of cells with IFN-7 compared to IFN-c~ or IFN-/3 (Weil et al., 1983) .
Analysis of cell supernatants after virus adsorption showed that more than 99 ~ of infectious virus particles were adsorbed to the cell membrane in IFN-treated as well as in control cells (data not shown). Thus, viral adsorption was unaffected by IFN. However, induction of the HSV/3-protein DNA polymerase was inhibited by IFN. Additionally, there was a delay in expression of /3-genes. This suggests that IFN might act on a-protein synthesis, because sufficient amounts of HSV immediate early a-proteins are required to trigger the synthesis of/3-proteins (Honess & Roizman, 1975) .
Our results indicate that IFN inhibits HSV replication at an early step. Similar findings have been made with mouse L-cells (Panet & Falk, 1983) and human HeLa cells (Gloger & Panet, 1984) . Contrary to these findings Mufioz & Carrasco (1984) reported no inhibition of HSV protein synthesis by IFN in HeLa cells which led them to suggest that IFN acts via the production of defective virions during the first virus cycle. Because of its high sensitivity to IFN the macrophage-HSV systemis useful to analyse further the step in viral replication cycle that is blocked by IFN. This might be during penetration of HSV through the cell membrane as shown for VSV (Whitaker-Dowling et al., 1983) or during the synthesis of a-proteins as indicated by Gloger & Panet (1984) .
Despite the fact that exogenous IFN was removed at the time of infection, there was no increase of virus yield in IFN-treated macrophages up to 3 days after infection. This continued restriction of viral growth is due to the production of endogenous IFN. Macrophages start producing IFN 9 h after infection and IFN titres of 100 IU/ml are still measurable 72 h after infection. After the addition of an antiserum against IFN-c~//3, virus yield increases 2 to 3 log10 (data not shown). Thus, the antiserum is active in vitro on splenic macrophages cultured for 1 week. In contrast, Belardelli et al. (1984) have shown with fresh peritoneal macrophages that anti-IFN globulin acts only in viz~o.
IFN is known to activate macrophage functions (Bielefeldt Ohmann et al., 1984; Blasi et al., 1984) . The efficient antiviral activity could be due to different mechanisms switched on by IFN. One might be unspecific phagocytosis; another method might be the (2' 5')oligoadenylate system and the protein kinase. The latter mechanisms have been shown to be involved in IFNmediated inhibition of lytic RNA viruses (for review, see Lengyel, 1982) . Recent studies with human cells indicate that the (2'-5')oligoadenylate system is not involved in IFN-mediated inhibition of HSV (Cayley et al., 1984) . We have initiated studies to test this system in mouse macrophages. So far we have shown an IFN-dependent induction of (2'-5')oligoadenylate synthetase and the protein kinase (data not shown). Further work is needed to characterize the mechanism activated by IFN in macrophages that is responsible for the inhibition of HSV.
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